Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Journal of the National Cancer Institute|January 23, 2021
Site of Recurrence and Survival After Surgery for Colorectal Peritoneal MetastasisEva Breuer, Monika Hebeisen, Marcel André Schneider, et al.
Virchows Archiv : an International Journal of Pathology|April 15, 2021
Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosisNazim Benzerdjeb, Peggy Dartigues, Vahan Kepenekian, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 24, 2021
Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)Jean-Baptiste Delhorme, Laurent Villeneuve, Olivier Bouché, et al.
Annales De Pathologie|March 18, 2014
[Peritoneal malignant mesothelioma: review and recent data]Éliane Mery, Juliette Hommell-Fontaine, Mathieu Capovilla, et al.
Annales De Pathologie|March 18, 2014
[Peritoneal pseudomyxoma: an overview emphasizing pathological assessment and therapeutic strategies]Peggy Dartigues, Sylvie Isaac, Laurent Villeneuve, et al.
Gynecologic Oncology|November 19, 2022
Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy: Cohort B of the TROPHIMMUN phase 2 trialBenoit You, Pierre-Adrien Bolze, Jean-Pierre Lotz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2020
Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II TrialBenoit You, Pierre-Adrien Bolze, Jean-Pierre Lotz, et al.
Pageof 10